Neostigmine methyl sulfate is a cholinesterase inhibitor in the carbamate class, used clinically to enhance acetylcholine activity at neuromuscular junctions for the treatment of myasthenia gravis, Ogilvie… Read more
Neostigmine methyl sulfate is a cholinesterase inhibitor in the carbamate class, used clinically to enhance acetylcholine activity at neuromuscular junctions for the treatment of myasthenia gravis, Ogilvie syndrome, and certain cases of urinary retention. This category provides essential reference standards for the active pharmaceutical ingredient, along with a comprehensive selection of pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope labelled compounds. Pharmaceutical and analytical laboratories utilize these high-quality materials for precise impurity profiling, method validation, and routine quality control testing of this cholinergic agent. By employing these materials, researchers can ensure accurate quantification and characterization of potential byproducts, such as 3-hydroxyphenyltrimethylammonium salts and related degradation compounds, supporting rigorous regulatory compliance and stability monitoring throughout the drug development and manufacturing lifecycle.
